hVIVO plc
hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker an… Read more
hVIVO plc (HVO) - Total Liabilities
Latest total liabilities as of June 2025: GBX42.04 Million GBX
Based on the latest financial reports, hVIVO plc (HVO) has total liabilities worth GBX42.04 Million GBX as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
hVIVO plc - Total Liabilities Trend (2011–2024)
This chart illustrates how hVIVO plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
hVIVO plc Competitors by Total Liabilities
The table below lists competitors of hVIVO plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Liberty Flour Mills Inc
PSE:LFM
|
Philippines | ₱1.70 Billion |
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
UK | GBX12.55 Million |
|
CN PETRO & CHEM -H- - Dusseldorf Stock Exchang
DU:CHU
|
Germany | €1.16 Trillion |
|
Handson Global Management (HGM) Limited
NSE:HGM
|
India | ₹542.29 Million |
|
DCI Advisors Limited
LSE:DCI
|
UK | GBX64.88 Million |
|
Bank Al-Habib Ltd
KAR:BAHL
|
Pakistan | PKRs2.95 Trillion |
Liability Composition Analysis (2011–2024)
This chart breaks down hVIVO plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how hVIVO plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for hVIVO plc (2011–2024)
The table below shows the annual total liabilities of hVIVO plc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX44.22 Million | -9.58% |
| 2023-12-31 | GBX48.90 Million | +56.93% |
| 2022-12-31 | GBX31.16 Million | +44.31% |
| 2021-12-31 | GBX21.59 Million | -17.73% |
| 2020-12-31 | GBX26.25 Million | +322.20% |
| 2019-12-31 | GBX6.22 Million | +60.42% |
| 2018-12-31 | GBX3.88 Million | +26.25% |
| 2017-12-31 | GBX3.07 Million | -15.90% |
| 2016-12-31 | GBX3.65 Million | -1.02% |
| 2015-12-31 | GBX3.69 Million | +12.97% |
| 2014-12-31 | GBX3.26 Million | +136.09% |
| 2013-12-31 | GBX1.38 Million | -9.56% |
| 2012-12-31 | GBX1.53 Million | -6.61% |
| 2011-12-31 | GBX1.64 Million | -- |